Abstract
The prevalence of allergic rhinitis(AR) in children has been estimated to be approximately 40%, almost half of them symptomatic by age 6 years. Incidence of allergic rhinitis is increasing and the disease is commonly overlooked because it is often mistaken for recurrent upper respiratory infections.
The majority of individuals with AR can be succesfully treated with antihistamines, intranasal corticosteroids and allergen immunotherapy. The treatment of AR improves the quality potentially reduce the development of asthma and other comlications.